BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models

Yuki Kagoya(Aichi Cancer Center), Naoto Hirano(Ontario Institute for Cancer Research)
Journal of Clinical Investigation
August 21, 2016
Cited by 214


Related Papers